Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock
Outset Medical Reports Second Quarter 2024 Financial Results
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to[...]
08/07/2024 | Press release | Distributed by Public on 08/07/2024 17:33
Please select the service you want to use:
Smartlinks | Webjet Limited | News | Technology | Internet | Finance | Security Markets | Security Markets | Company News | Securities Issuers | E-Commerce Companies | Frankfurt Stock Exchange | Australian Securities Exchange (ASX) | Berlin Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | BX Swiss | Tradegate Exchange | Chi-X Australia
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact